NYSE · AACT-UN
Ares Acquisition Corporation II
$10.00-$0.01 (-0.1%)
Ares Acquisition Corporation II’s quoted price sits in the lower half of its reported 52-week range, 37.07% below the high.
Loading market information…
NYSE · HHLA · USD
Stock price, earnings
Quote as of Feb 9, 2024, 04:31 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
HH&L Acquisition Co.’s quoted price sits in the lower half of its reported 52-week range, 4.87% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow HH&L Acquisition Co.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
HH&L Acquisition Co. currently maintains no substantive business operations. Its primary objective is to engage in a strategic business combination, such as a merger, asset purchase, or share exchange, with one or more existing entities. The firm has a particular interest in seeking out opportunities within the healthcare or health-related industries located across various Asian markets. Established in 2020, HH&L Acquisition Co. operates from its headquarters in Central, Hong Kong.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.00-$0.01 (-0.1%)
Ares Acquisition Corporation II’s quoted price sits in the lower half of its reported 52-week range, 37.07% below the high.
$10.66-$0.04 (-0.37%)
Apollo Strategic Growth Capital II’s quoted price sits in the lower half of its reported 52-week range, 12.34% below the high.
$10.41-$0.00 (-0.01%)
AfterNext HealthTech Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 1.79% below the high.
$11.39+$0.07 (+0.62%)
Jaws Mustang Acquisition Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.26% below the high.
$25.97+$12.27 (+89.56%)
Digital Transformation Opportunities Corp.’s quoted price sits in the upper half of its reported 52-week range, 34.42% below the high.
$10.95-$0.01 (-0.09%)
CC Neuberger Principal Holdings III’s quoted price sits in the upper half of its reported 52-week range, 5.6% below the high.
$10.45+$0.00 (0.0%)
Acropolis Infrastructure Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.1% below the high.
$10.69+$0.01 (+0.09%)
African Gold Acquisition Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
